ATE129411T1 - Natriumhyaluronat-zusammensetzung. - Google Patents

Natriumhyaluronat-zusammensetzung.

Info

Publication number
ATE129411T1
ATE129411T1 AT90104673T AT90104673T ATE129411T1 AT E129411 T1 ATE129411 T1 AT E129411T1 AT 90104673 T AT90104673 T AT 90104673T AT 90104673 T AT90104673 T AT 90104673T AT E129411 T1 ATE129411 T1 AT E129411T1
Authority
AT
Austria
Prior art keywords
sodium hyaluronate
hyaluronate composition
hyaluronate
composition
opthalamological
Prior art date
Application number
AT90104673T
Other languages
English (en)
Inventor
David A Swann
Bernard P Sullivan
Dale P Devore
Original Assignee
Medchem Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25674005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE129411(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medchem Products Inc filed Critical Medchem Products Inc
Application granted granted Critical
Publication of ATE129411T1 publication Critical patent/ATE129411T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
AT90104673T 1988-05-16 1990-03-12 Natriumhyaluronat-zusammensetzung. ATE129411T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/194,187 US4920104A (en) 1988-05-16 1988-05-16 Sodium hyaluronate composition
CA002011956A CA2011956C (en) 1988-05-16 1990-03-12 Sodium hyaluronate composition

Publications (1)

Publication Number Publication Date
ATE129411T1 true ATE129411T1 (de) 1995-11-15

Family

ID=25674005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90104673T ATE129411T1 (de) 1988-05-16 1990-03-12 Natriumhyaluronat-zusammensetzung.

Country Status (6)

Country Link
US (1) US4920104A (de)
EP (1) EP0399156B1 (de)
JP (1) JP3065327B2 (de)
AT (1) ATE129411T1 (de)
CA (1) CA2011956C (de)
DE (1) DE69023163T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7312291A (en) * 1990-02-13 1991-09-03 Gere S. Dizerega Peritoneal induced medicaments
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1254712B (it) * 1992-01-20 1995-10-09 Uso dell'acido ialuronico lubrificante di protesi oculari.
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
JP2002501483A (ja) * 1997-02-13 2002-01-15 ボシュ アンド ロム サージカル，インコーポレイテッド 網膜色素上皮細胞を破壊するための方法
SE9700827D0 (sv) * 1997-03-07 1997-03-07 Pharmacia & Upjohn Ab Ophthalmic composition
US6368585B1 (en) 1997-03-25 2002-04-09 Pharmacia Ab Opthalmic compositions and methods
US6638917B1 (en) 2000-02-25 2003-10-28 Scimed Life Systems, Inc. Reducing adhesion
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
WO2005072701A1 (en) 2004-01-20 2005-08-11 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20060009498A1 (en) * 2004-07-12 2006-01-12 Allergan, Inc. Ophthalmic compositions and methods for treating ophthalmic conditions
US20060159651A1 (en) * 2005-01-14 2006-07-20 Michael Colvard Gradient molecular weight viscoelastic solutions
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US9039761B2 (en) 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
WO2011057275A2 (en) * 2009-11-09 2011-05-12 Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University Molecular films for hydrophobic implant surfaces
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4328803B1 (en) * 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4713375A (en) * 1985-08-01 1987-12-15 Lindstrom Richard L Viscoelastic solution

Also Published As

Publication number Publication date
US4920104A (en) 1990-04-24
EP0399156A1 (de) 1990-11-28
JPH03271228A (ja) 1991-12-03
CA2011956C (en) 1998-02-03
JP3065327B2 (ja) 2000-07-17
DE69023163T2 (de) 1996-06-27
DE69023163D1 (de) 1995-11-30
CA2011956A1 (en) 1991-09-12
EP0399156B1 (de) 1995-10-25

Similar Documents

Publication Publication Date Title
DE69023163D1 (de) Natriumhyaluronat-Zusammensetzung.
SE8900586L (sv) Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
EP1154287A3 (de) Sauerstoffdurchlässige Kontaktlinse mit hydrophiler Oberfläche und Verfahren zur Herstellung derselben
ATE233083T1 (de) Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
DK0781547T3 (da) Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
KR890004720A (ko) 성장 인자를 함유하는 겔 제형
KR890011918A (ko) 개선된 의료용 폴리(프로필렌 글리콜 푸마레이트)조성물
NO180668C (no) Kryss-bundede, sårsekretabsorberende hydrogeler
ATE153346T1 (de) Oxidationsresistente analoga des thrombomodulins
DE69925821D1 (de) Zusammensetzungen enthaltend Heparin mit niedrigem Molekülargewicht
IT1287227B1 (it) Acido ialuronico quale componente del liquido di conservazione della cornea
ES8800605A1 (es) Procedimiento para preparar una composicion coloeada de utilidad en cirugia ocular.
CA2282757A1 (en) Opthalmic composition
DK0594770T3 (da) Oftalmologiske blandinger
AU6243601A (en) Use a high-molecular-weight extracellular haemoglobin as blood substitute
ATE325828T1 (de) Polymerträger mit polyoxalkylenen
FI934902A0 (fi) Genetisk kontroll av acetylening och puryvylening av xantan baserade polysackaridpolymerer
BR0115154A (pt) material viscoelástico transicional não-aspirante para uso em cirurgia
IT1254712B (it) Uso dell'acido ialuronico lubrificante di protesi oculari.
ATE183103T1 (de) Resorbierbare knochendichtungsmittel
TH10169A (th) สารผสมสำหรับเครื่องสำอาง
ES8307867A1 (es) "un procedimiento para preparar hidrogeles que retienen la forma a base de colageno solubilizado, utiles por ejemplo para fines medicos y cosmeticos".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee